SPRB NASDAQ
Spruce Biosciences, Inc.
1W: -6.2%
1M: -23.4%
3M: -11.8%
YTD: -49.6%
1Y: +413.6%
3Y: -72.9%
5Y: -90.3%
$45.71
+0.94 (+2.10%)
Weekly Expected Move ±7.3%
$39
$42
$46
$49
$52
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-01-09
Earliest Filing
2026-03-09
Latest Filing
partner: 2
target: 1
Counterparties (Filed by SPRB)
3 relationshipsCompanies named in SPRB's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Jefferies LLC | JEF | partner | Sales agent and principal for the Open Market Sale Agreement | 2026-03-09 | View |
| Eiger BioPharmaceuticals, Inc. | — | target | Seller of Avexitide assets in a stalking horse asset purchase agreement. | 2024-06-18 | View |
| Kaken Pharmaceutical Co., LTD. | — | partner | Exclusive collaboration and license agreement for tildacerfont in Japan and other regions | 2023-01-09 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-12 | Earnings Release; Exhibits | View | |
| 2026-07-27 | Officer/Director Change | View | |
| 2026-05-26 | Shareholder Vote; Exhibits | View | |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-04-22 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-03-09 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Results of O | Agreement | View |
| 2026-02-05 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-01-08 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Creation of | Agreement | View |
| 2025-12-15 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-12 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-17 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-10-08 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-24 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-06-12 | Notice of Delisting or Transfer; Other Events; Financial Statements and Exhibits | View | |
| 2025-05-29 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2025-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-25 | Costs Associated with Exit or Disposal Activities; Notice of Delisting or Transfer; Financial Statem | View | |
| 2025-04-15 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR